Article: Recent progress on anticancer candidates in patents of herbal medicinal products

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleRecent progress on anticancer candidates in patents of herbal medicinal products
AuthorsFeng, Y
Wang, N1
Zhu, M1
Feng, Y1
Li, H2
Tsao, S1
KeywordsAnticancer drugs
Antimetastasis drugs
Chinese medicines
Complementary and alternative medicines
Herbal medicine
Patent
Issue Date2011
PublisherBentham Science Publishers Ltd. The Journal's web site is located at http://www.bentham.org/pfna/index.htm
CitationRecent Patents On Food, Nutrition And Agriculture, 2011, v. 3 n. 1, p. 30-48 [How to Cite?]
DOI: http://dx.doi.org/10.2174/1876142911103010030
AbstractHerbal medicines in treatment of cancer as complementary and alternative therapy are accepted increasingly with growing scientific evidences of biomedical research and clinical trials. Anticancer drugs discovered from herbal medicines have a long history and some of them have been used in clinical setting as the conventional anticancer drugs. Actually, herbal medicines are a source for anticancer drug discovery and drug development. Recently, research continuously focuses on clues from traditional use of herbal medicines to develop new anticancer drugs in single pure compounds. On the other hand, standardized various extracts or fractions with anticancer effects or with adjuvant therapy in cancer treatment coming from single or mixed herbs are also accepted forms as dietary supplements and botanical drug products in the US for current statutory regulations. In the present paper, we analyzed the patented agents in the US from herbal medicines in recent ten years, both as potential anticancer extracts/fractions (containing multi-components) and single pure compound(s) that act as new anticancer substances. This review also highlighted the advances in knowledge about quality control, safety, efficacy and recent progress in anticancer candidates in patents of botanical drug products from herbal medicines. © 2011 Bentham Science Publishers Ltd.
ISSN2212-7984
DOIhttp://dx.doi.org/10.2174/1876142911103010030
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorFeng, Y
dc.contributor.authorWang, N
dc.contributor.authorZhu, M
dc.contributor.authorFeng, Y
dc.contributor.authorLi, H
dc.contributor.authorTsao, S
dc.date.accessioned2011-08-26T14:41:19Z
dc.date.available2011-08-26T14:41:19Z
dc.date.issued2011
dc.description.abstractHerbal medicines in treatment of cancer as complementary and alternative therapy are accepted increasingly with growing scientific evidences of biomedical research and clinical trials. Anticancer drugs discovered from herbal medicines have a long history and some of them have been used in clinical setting as the conventional anticancer drugs. Actually, herbal medicines are a source for anticancer drug discovery and drug development. Recently, research continuously focuses on clues from traditional use of herbal medicines to develop new anticancer drugs in single pure compounds. On the other hand, standardized various extracts or fractions with anticancer effects or with adjuvant therapy in cancer treatment coming from single or mixed herbs are also accepted forms as dietary supplements and botanical drug products in the US for current statutory regulations. In the present paper, we analyzed the patented agents in the US from herbal medicines in recent ten years, both as potential anticancer extracts/fractions (containing multi-components) and single pure compound(s) that act as new anticancer substances. This review also highlighted the advances in knowledge about quality control, safety, efficacy and recent progress in anticancer candidates in patents of botanical drug products from herbal medicines. © 2011 Bentham Science Publishers Ltd.
dc.description.naturepostprint
dc.identifier.citationRecent Patents On Food, Nutrition And Agriculture, 2011, v. 3 n. 1, p. 30-48 [How to Cite?]
DOI: http://dx.doi.org/10.2174/1876142911103010030
dc.identifier.doihttp://dx.doi.org/10.2174/1876142911103010030
dc.identifier.epage48
dc.identifier.hkuros191220
dc.identifier.issn2212-7984
dc.identifier.issue1
dc.identifier.openurl
dc.identifier.pmid21114469
dc.identifier.scopuseid_2-s2.0-79955007154
dc.identifier.spage30
dc.identifier.urihttp://hdl.handle.net/10722/138137
dc.identifier.volume3
dc.languageeng
dc.publisherBentham Science Publishers Ltd. The Journal's web site is located at http://www.bentham.org/pfna/index.htm
dc.publisher.placeNetherlands
dc.relation.ispartofRecent Patents on Food, Nutrition and Agriculture
dc.relation.referencesReferences in Scopus
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
dc.subject.meshAntineoplastic Agents, Phytogenic - adverse effects - therapeutic use
dc.subject.meshDrug Discovery
dc.subject.meshNeoplasms - drug therapy
dc.subject.meshPhytotherapy
dc.subject.meshPlant Extracts - adverse effects - therapeutic use
dc.subjectAnticancer drugs
dc.subjectAntimetastasis drugs
dc.subjectChinese medicines
dc.subjectComplementary and alternative medicines
dc.subjectHerbal medicine
dc.subjectPatent
dc.titleRecent progress on anticancer candidates in patents of herbal medicinal products
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong
  2. Sun Yat-Sen University